Interestingly, antibody- and peptide-mediated targeting of NCL induced normalization of tumor vasculature in pancreas and breast cancer models (53, 69), further suggesting that strategies targeting NCL might affect the GBM vasculature. The gene discussed is NUCLEOLIN; the disease is glioblastoma.